ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1919

Financial insecurity and discrimination are associated with patient-reported quality of life in patients with SLE

Heather Gold1, Yi Li1, Peter Izmirly2, Jill Buyon1, Mala Masson3, Amit Saxena1, H Michael Belmont4, Chung-E Tseng5 and Rebecca Anthopolos1, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Health, New York, 4NYU School of Medicine, New York, NY, 5New York University Grossman School of Medicine, Flushing, NY

Meeting: ACR Convergence 2025

Keywords: quality of life, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1914–1935) Health Services Research Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Manifestations of SLE are known to affect patient-reported outcome measures (PROs) such as physical function, fatigue, and pain. Other work has suggested economic insecurity is associated with worse PRO scores, and discrimination can have a chronic effect on health status. This study focused on the association of PROs with individual and structural socioeconomic factors and SLE-related clinical variables.

Methods: A cohort of patients (n=272) diagnosed with SLE according to standard classification criteria (ACR revised classification, European Alliance of Association for Rheumatology/ACR classification, or SLICC classification) were surveyed using measures from the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) for physical function, cognitive function, pain interference, fatigue, anxiety, sleep disturbance, and depression. Analyses included demographics, financial/material insecurity such as in housing, finances, healthcare, or job status, and clinical data on disease activity (any of cutaneous, nephritis or arthritis) and immunosuppressive medication use. Everyday Discrimination Scale was captured to quantify the potential impact of discrimination and its associated chronic stress on health (coded as never vs ever experienced 9 discrimination types and summed across types). Multivariable linear regression models of PROs included clinical and socioeconomic factors.

Results: The cohort was 90% female, 28% African American/Black, 17% Asian, 39% white, and 16% other/unknown, with an average age of 40 years. Average SLEDAI was 3.17 (SD=3.52) and SLICC damage score 1.12 (SD=1.53). Multivariable models showed that experiencing financial insecurity was associated with significantly worse scores on all PROs, from 4-7 points worse (p< 0.01). Each additional point on the Everyday Discrimination Scale was associated significantly with 1 point worse on physical and cognitive function score, 1 point higher sleep disturbance, depression, and anxiety, and 2 points higher on fatigue on average (p< 0.05). Finally, experiencing disease activity was significantly associated with lower physical function and higher sleep disturbance, depression, and anxiety (p< 0.05). (Table)

Conclusion: Experiencing financial insecurity was associated with clinically important negative impacts in function and symptom PROs; everyday discrimination consistently significantly negatively affected PRO scores; and disease activity was negatively associated with 4 of the 7 measures. Understanding the full experience of patients with SLE, beyond their clinical manifestations, may help identify approaches to support patients for improved function and reduced symtpoms.

Supporting image 1


Disclosures: H. Gold: None; Y. Li: None; P. Izmirly: Hansoh Bio, 2; J. Buyon: Artiva Biotherapeutics, 2, Biogen, 2, Bristol-Myers Squibb(BMS), 2, Celgene, 2, CLIMB Bio Operating, 2, GlaxoSmithKlein(GSK), 2, Janssen, 2, Related Sciences, 2, UCB, 2; M. Masson: None; A. Saxena: AbbVie/Abbott, 1, Amgen, 1, AstraZeneca, 1, Aurinia, 1, 6, Bristol-Myers Squibb(BMS), 1, GlaxoSmithKlein(GSK), 5, Synthekine, 1, 2, UCB, 1, 6; H. Belmont: None; C. Tseng: None; R. Anthopolos: None.

To cite this abstract in AMA style:

Gold H, Li Y, Izmirly P, Buyon J, Masson M, Saxena A, Belmont H, Tseng C, Anthopolos R. Financial insecurity and discrimination are associated with patient-reported quality of life in patients with SLE [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/financial-insecurity-and-discrimination-are-associated-with-patient-reported-quality-of-life-in-patients-with-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/financial-insecurity-and-discrimination-are-associated-with-patient-reported-quality-of-life-in-patients-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology